Iontophoretic delivery device with single lamina electrode

• US 5,618,265 A
• Filed: 01/26/1996
• Issued: 04/08/1997
• Est. Priority Date: 03/11/1991
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Myers, Robert M., Landrau, Felix A.
• Primary Examiner(s): Bockelman, Mark
• Application Number:
  US08/592,083
• Time in Patent Office: 438 Days
• Field of Search: 604/20, 604/890.1, 607/149, 607/152, 607/115, 264/104-105, 264/126, 264/160, 424/422-438, 424/447-449
• US Class Current: 604/20
• CPC Class Codes: A61N 1/0436 Material of the electrode
• CPC Class Codes: A61N 1/0448 Drug reservoir
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Abstract

An electrically powered transdermal iontophoretic delivery device (10, 20) and a method of making same is provided. The device utilizes electrode assemblies (8, 9 ) composed of a substantially homogenous blend of a polymeric matrix containing about 5 to 50 vol % of a conductive filler which forms a conductive network through the matrix, and up to about 50 vol % of the agent to be iontophoretically delivered through the skin. In the case of the donor electrode assembly, the agent is typically a drug and preferably a water soluble drug salt. In the case of the counter electrode assembly, the agent is typically an electrolyte salt. The homogenous blend eliminates the need for separate electrode and agent containing layers which require lamination.

Claims

1. An electrically powered iontophoretic delivery device including a donor electrode assembly adapted to be placed in agent transmitting relation with a body surface, a counter electrode assembly adapted to be placed in agent transmitting relation with a body surface and a source of electrical power adapted to be electrically connected to the donor electrode assembly and the counter electrode assembly, wherein the donor electrode assembly comprises

a polymeric matrix having a predetermined thickness, said matrix having homogeneously blended therein:

about 5 to 50 vol % of a conductive filler forming a conductive network through the entire thickness of the matrix; and

about 1 to 50 vol % of a therapeutic agent to be iontophoretically delivered through the body surface in order to obtain a therapeutic effect.

2. The device of claim 1, wherein the polymeric matrix is selected from the group consisting of hydrophilic polymers, hydrophobic polymers and blends thereof.

3. The device of claim 2, wherein the polymeric matrix is comprised of a hydrophobic polymer selected from the group consisting of ethylene vinyl acetate copolymers, polyalkylenes, polyisoprenes, rubbers, polyisobutylene, polyvinylacetate, polyamides, polyurethanes, polyvinylchlorides, and modified cellulosic polymers.

4. The device of claim 2, wherein the polymeric matrix is comprised of a hydrophilic polymer selected from the group consisting of hydrogels, polyethylene oxides, cellulosic polymers, polyacrylic acids and polyvinyl pyrrolidones.

5. The device of claim 2, wherein the polymeric matrix comprises polyvinyl pyrrolidone.

6. The device of claim 1, wherein the polymeric matrix comprises an ethylene vinyl acetate copolymer.

7. The device of claim 1, containing about 15 to 30 vol. % of the conductive filler.

8. The device of claim 1, containing about 20 to 25 vol. % of the conductive filler.

9. The device of claim 1, wherein the conductive filler comprises an electrochemically reactive material able to undergo oxidation or reduction during operation of the device.

10. The device of claim 9, wherein the electrochemically reactive material is selected from the group consisting of Ag, Zn, Cu, silver halides, copper halides and Ag₄ Fe(CN)₆.

11. The device of claim 1, wherein the conductive filler comprises an electrochemically inert material.

12. The device of claim 11, wherein the conductive filler is selected from the group consisting of carbon or graphite fibers, powdered carbon or graphite and electrochemically inert metals.

13. The device of claim 12, wherein the inert metal is selected from the group consisting of platinum, palladium, gold and stainless steel.

14. The device of claim 1, wherein a plurality of fluid flow pathways are provided through the electrode assembly.

15. The device of claim 14, wherein the fluid flow pathways are provided by a soluble pore forming agent in the polymeric matrix.

16. The device of claim 1, containing about 10 to 50 vol % of the therapeutic agent.

17. The device of claim 1, containing about 20 to 35 vol % of the therapeutic agent.

18. The device of claim 1, wherein the polymeric matrix comprised of about 10 to 60 wt % of a hydrophilic polymer and about 10 to 60 wt % of a hydrophobic polymer.

19. The device of claim 1, wherein the power source comprises a battery.